Alpha DNA Investment Management’s Workiva WK Stock Holding History
Bought
Maintained
Sold
Other funds holding WK
RP
PIMC
CIP
Alpha DNA Investment Management's WK Position: Q1 2022 in Review
Alpha DNA Investment Management sold out of Workiva (WK) in Q1 2022, closing a stake of 10,944 shares — an estimated $1.43M sold.
Alpha DNA Investment Management first reported a position in WK in Q1 2021 and held it in 2 quarters. The position peaked at $1.43M in Q4 2021. 288 funds tracked by Wall St. Rank hold WK as of Q1 2022.
- Alpha DNA Investment Management reported no remaining Workiva position as of Q1 2022 after selling out during the quarter.
- Alpha DNA Investment Management sold 10,944 Workiva shares in Q1 2022, an estimated $1.43M.
- Alpha DNA Investment Management first reported a position in Workiva in Q1 2021 and held it in 2 quarters.
- Alpha DNA Investment Management's Workiva position peaked at $1.43M in Q4 2021.
- 288 funds tracked by Wall St. Rank held Workiva as of Q1 2022.
Based on Alpha DNA Investment Management's 13F filing for Q1 2022, filed 13 May 2022.